Skip to content

Accurate sampling method of prostate cancer tissues with 3D stereo location

Accurate sampling method of prostate cancer tissues with 3D stereo location

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071287
Enrollment
Unknown
Registered
2023-05-10
Start date
2020-11-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

Group of prostate cancer tissue collected by 3D stereoscopic localization:N/A
Cognitive sampling of prostate cancer tissue group:N/A

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
57 Years to 82 Years

Inclusion criteria

Inclusion criteria: 1. mpMRI was performed in our hospital before surgery, and the diagnosis was made by perineal prostate biopsy. The number of biopsy positive needles was obtained, and Gleason score was obtained through biopsy. 2. Prostate cancer patients with a clear Gleason score who have undergone radical prostatectomy. 3. mpMRI data of all patients can be imported into 3D modeling software.

Exclusion criteria

Exclusion criteria: 1. No significant abnormal prostate nodules were found on prostate mpMRI or MRI after neoadjuvant therapy. 2. The prostate is invaded by lesions of surrounding organs.

Design outcomes

Primary

MeasureTime frame
Prostatic pathology;Positive sampling rate ;Tumor volume;Prostate-specific antigen;Prostate specific antigen density;

Countries

China

Contacts

Public ContactWei Xuedong

The First Affiliated Hospital of Soochow University

wxd0422@163.com+86 189 1406 1080

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026